Dataset Information
Degarelix for treating advanced hormone-sensitive prostate cancer.
Ontology highlight
ABSTRACT:
SUBMITTER: Zengerling F
PROVIDER: S-EPMC8407409 | biostudies-literature | 2021 Aug
REPOSITORIES: biostudies-literature
Publications
Degarelix for treating advanced hormone-sensitive prostate cancer.
The Cochrane database of systematic reviews 20210805
<h4>Background</h4>Degarelix is a gonadotropin-releasing hormone antagonist that leads to medical castration used to treat men with advanced or metastatic prostate cancer, or both. It is unclear how its effects compare to standard androgen suppression therapy.<h4>Objectives</h4>To assess the effects of degree compared with standard androgen suppression therapy for men with advanced hormone-sensitive prostate cancer.<h4>Search methods</h4>We searched multiple databases (CENTRAL, MEDLINE, Embase, ...[more]